Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy
about
Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@ast
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@en
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@nl
type
label
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@ast
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@en
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@nl
prefLabel
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@ast
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@en
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@nl
P2093
P2860
P1433
P1476
Autologous aldrithiol-2-inacti ...... c dendritic cell immunotherapy
@en
P2093
Andres Salazar
Charles Mac Trubey
Elena Chertova
Elizabeth Miller
Jeffrey Lifson
Julian Bess
Meredith Spadaccia
Nina Bhardwaj
Rachel Sabado
Rose Marie Holman
P2860
P304
P356
10.1016/J.VACCINE.2014.10.054
P407
P577
2014-11-15T00:00:00Z